MedTrace Logo

Oral Versus Intravenous Dexamethasone

NCT01390012 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-01-15

No results posted yet for this study

Summary

The purpose of this study is to assess bioequivalence for dexamethasone administered orally versus intravenously in patients admitted to hospital for pneumonia.

Conditions

Interventions

DRUG

Dexamethasone tablet 6 mg

Dexamethasone tablet 6 mg

DRUG

Dexamethasone injection 4 mg

Dexamethasone injection 4 mg

Sponsors & Collaborators

  • St. Antonius Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390012 on ClinicalTrials.gov